Inventor · disambiguated record
Henrik C. Hansen
Also filed as: HANSEN HENRIK C · HANSEN HENRIK CHRISTIAN
20 granted patents·7 pending applications·835 citations·filing 1996–2024
96Inventor score
Top patents by PatentIndex Score
27 records- 0197US8053440B2Compounds for the prevention and treatment of cardiovascular diseasesRESVERLOGIX CORP·Filed 2007·Granted Nov 8, 2011·53 cites·34 claims
- 0295US8093273B2Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseasesWONG NORMAN C W·Filed 2005·Granted Jan 10, 2012·46 cites·8 claims
- 0395US7846915B2Stilbenes and chalcones for the prevention and treatment of cardiovascular diseasesRESVERLOGIX CORP·Filed 2005·Granted Dec 7, 2010·33 cites·13 claims
- 0494US8242130B2Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseasesWONG NORMAN C W·Filed 2009·Granted Aug 14, 2012·22 cites·12 claims
- 0594US8242144B2Stilbenes and chalcones for the prevention and treatment of cardiovascular diseasesWONG NORMAN C W·Filed 2010·Granted Aug 14, 2012·23 cites·7 claims
- 0693US8952021B2Compounds for the prevention and treatment of cardiovascular diseaseHANSEN HENRIK C·Filed 2010·Granted Feb 10, 2015·14 cites·16 claims
- 0792US8889698B2Compounds for the prevention and treatment of cardiovascular diseasesHANSEN HENRIK C·Filed 2011·Granted Nov 18, 2014·14 cites·30 claims
- 0892US8114995B2Methods of preparing quinazolinone derivativesHANSEN HENRIK C·Filed 2009·Granted Feb 14, 2012·45 cites·7 claims
- 0991US8410109B2Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devicesWONG NORMAN C W·Filed 2006·Granted Apr 2, 2013·31 cites·2 claims
- 1090US9199990B2Compounds for the prevention and treatment of cardiovascular diseasesHANSEN HENRIK C·Filed 2014·Granted Dec 1, 2015·9 cites·50 claims
- 1188US11407719B2Anti-inflammatory agentsRESVERLOGIX CORP·Filed 2020·Granted Aug 9, 2022·1 cites·6 claims
- 1288US5714225ASkin plate productCOLOPLAST AS·Filed 1996·Granted Feb 3, 1998·455 cites·20 claims
- 1387US9238640B2Anti-inflammatory agentsHANSEN HENRIK C·Filed 2010·Granted Jan 19, 2016·9 cites·20 claims
- 1483US10532054B2Compounds for the prevention and treatment of cardiovascular diseasesRESVERLOGIX CORP·Filed 2017·Granted Jan 14, 2020·2 cites·34 claims
- 1581US10882828B2Anti-inflammatory agentsRESVERLOGIX CORP·Filed 2018·Granted Jan 5, 2021·1 cites·12 claims
- 1681US9757368B2Anti-inflammatory agentsHANSEN HENRIK C·Filed 2010·Granted Sep 12, 2017·8 cites·36 claims
- 1777US2021361656A1Compounds for the prevention and treatment of cardiovascular diseasesRESVERLOGIX CORP·Filed 2021·Application pending·0 cites
- 1873US10131640B2Anti-inflammatory agentsRESVERLOGIX CORP·Filed 2015·Granted Nov 20, 2018·1 cites·39 claims
- 1973US2020352946A1Compounds for the prevention and treatment of cardiovascular diseasesRESVERLOGIX CORP·Filed 2019·Application pending·0 cites
- 2068US10772894B2Compositions and therapeutic methods for the treatment of complement-associated diseasesRESVERLOGIX CORP·Filed 2018·Granted Sep 15, 2020·1 cites·6 claims
- 2164US12145932B2Method of manufacturing a solid form of a BET bromodomain inhibitorZENITH EPIGENETICS LTD·Filed 2019·Granted Nov 19, 2024·0 cites·21 claims
- 2263US2025034142A1Method of manufacturing a solid form of a bet bromodomain inhibitorZENITH EPIGENETICS LTD·Filed 2024·Application pending·0 cites
- 2358US2020129512A1Novel anti-inflammatory agentsRESVERLOGIX CORP·Filed 2019·Application pending·0 cites
- 2458US2016106750A1Compounds for the prevention and treatment of cardiovascular diseasesHANSEN HENRIK C·Filed 2015·Application pending·0 cites
- 2554US6849070B1Catheter setCOLOPLAST AS·Filed 1999·Granted Feb 1, 2005·67 cites·26 claims
- 2652US2017333419A1Novel anti-inflammatory agentsRESVERLOGIX CORP·Filed 2017·Application pending·0 cites
- 2751US2017326143A1Novel anti-inflammatory agentsRESVERIOGIX CORP·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henrik C. Hansen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →